175 related articles for article (PubMed ID: 18528842)
1. Detection of pancreatic cancer using antibody microarray-based serum protein profiling.
Ingvarsson J; Wingren C; Carlsson A; Ellmark P; Wahren B; Engström G; Harmenberg U; Krogh M; Peterson C; Borrebaeck CA
Proteomics; 2008 Jun; 8(11):2211-9. PubMed ID: 18528842
[TBL] [Abstract][Full Text] [Related]
2. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.
Carlsson A; Wingren C; Ingvarsson J; Ellmark P; Baldertorp B; Fernö M; Olsson H; Borrebaeck CA
Eur J Cancer; 2008 Feb; 44(3):472-80. PubMed ID: 18171612
[TBL] [Abstract][Full Text] [Related]
3. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.
Gao WM; Kuick R; Orchekowski RP; Misek DE; Qiu J; Greenberg AK; Rom WN; Brenner DE; Omenn GS; Haab BB; Hanash SM
BMC Cancer; 2005 Aug; 5():110. PubMed ID: 16117833
[TBL] [Abstract][Full Text] [Related]
4. Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer.
Orchekowski R; Hamelinck D; Li L; Gliwa E; vanBrocklin M; Marrero JA; Vande Woude GF; Feng Z; Brand R; Haab BB
Cancer Res; 2005 Dec; 65(23):11193-202. PubMed ID: 16322270
[TBL] [Abstract][Full Text] [Related]
5. Design of recombinant antibody microarrays for serum protein profiling: targeting of complement proteins.
Ingvarsson J; Larsson A; Sjöholm AG; Truedsson L; Jansson B; Borrebaeck CA; Wingren C
J Proteome Res; 2007 Sep; 6(9):3527-36. PubMed ID: 17696517
[TBL] [Abstract][Full Text] [Related]
6. Protein profiling in human sera for identification of potential lung cancer biomarkers using antibody microarray.
Han MK; Oh YH; Kang J; Kim YP; Seo S; Kim J; Park K; Kim HS
Proteomics; 2009 Dec; 9(24):5544-52. PubMed ID: 20017155
[TBL] [Abstract][Full Text] [Related]
7. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
8. High-throughput proteomics using antibody microarrays: an update.
Borrebaeck CA; Wingren C
Expert Rev Mol Diagn; 2007 Sep; 7(5):673-86. PubMed ID: 17892372
[TBL] [Abstract][Full Text] [Related]
9. Design of recombinant antibody microarrays for complex proteome analysis: choice of sample labeling-tag and solid support.
Wingren C; Ingvarsson J; Dexlin L; Szul D; Borrebaeck CA
Proteomics; 2007 Sep; 7(17):3055-65. PubMed ID: 17787036
[TBL] [Abstract][Full Text] [Related]
10. [Application of serum protein profiling in diagnosis, prognosis and evaluation of curative effect of pancreatic adenocarcinoma].
Guo JH; Wang WJ; Liao P; Zhang CY; Jin DY; Lou WH; Zhang SC
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):33-6. PubMed ID: 20211064
[TBL] [Abstract][Full Text] [Related]
11. Single framework recombinant antibody fragments designed for protein chip applications.
Steinhauer C; Wingren C; Hager AC; Borrebaeck CA
Biotechniques; 2002 Dec; Suppl():38-45. PubMed ID: 12514928
[TBL] [Abstract][Full Text] [Related]
12. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers.
Miller JC; Zhou H; Kwekel J; Cavallo R; Burke J; Butler EB; Teh BS; Haab BB
Proteomics; 2003 Jan; 3(1):56-63. PubMed ID: 12548634
[TBL] [Abstract][Full Text] [Related]
13. [A predictive model for pancreatic cancer using serum protein footprint map].
Long J; Di Y; Jin C; Yu XJ; Liu WW; Chen YM; Fu DL; Ni QX
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1533-6. PubMed ID: 18956633
[TBL] [Abstract][Full Text] [Related]
14. A cancer protein microarray platform using antibody fragments and its clinical applications.
Song S; Li B; Wang L; Wu H; Hu J; Li M; Fan C
Mol Biosyst; 2007 Feb; 3(2):151-8. PubMed ID: 17245494
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomic analysis of human pancreatic juice: methodological study.
Zhou L; Lu Z; Yang A; Deng R; Mai C; Sang X; Faber KN; Lu X
Proteomics; 2007 Apr; 7(8):1345-55. PubMed ID: 17443640
[TBL] [Abstract][Full Text] [Related]
16. Biomarker identification in human pancreatic cancer sera.
Hanas JS; Hocker JR; Cheung JY; Larabee JL; Lerner MR; Lightfoot SA; Morgan DL; Denson KD; Prejeant KC; Gusev Y; Smith BJ; Hanas RJ; Postier RG; Brackett DJ
Pancreas; 2008 Jan; 36(1):61-9. PubMed ID: 18192883
[TBL] [Abstract][Full Text] [Related]
17. Improved affinity coupling for antibody microarrays: engineering of double-(His)6-tagged single framework recombinant antibody fragments.
Steinhauer C; Wingren C; Khan F; He M; Taussig MJ; Borrebaeck CA
Proteomics; 2006 Aug; 6(15):4227-34. PubMed ID: 16826567
[TBL] [Abstract][Full Text] [Related]
18. Identification of multi-SH3 domain-containing protein interactome in pancreatic cancer: a yeast two-hybrid approach.
Thalappilly S; Suliman M; Gayet O; Soubeyran P; Hermant A; Lecine P; Iovanna JL; Dusetti NJ
Proteomics; 2008 Aug; 8(15):3071-81. PubMed ID: 18654987
[TBL] [Abstract][Full Text] [Related]
19. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
20. Immobilization strategies for single-chain antibody microarrays.
Seurynck-Servoss SL; Baird CL; Miller KD; Pefaur NB; Gonzalez RM; Apiyo DO; Engelmann HE; Srivastava S; Kagan J; Rodland KD; Zangar RC
Proteomics; 2008 Jun; 8(11):2199-210. PubMed ID: 18452230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
